11 million Acetaminophen bottles recalled by FDA
28.11.2008 06:01Alpha Synuclein-rPeptide Introduces New Proteins
Alpha Synuclein, 1-60
MW: 6,149 Da
Lyophilized powder. Purity > 95% by SDS-PAGE; A deletion mutant of Alpha-Synuclein (amino acids 1-60), which contains the N-terminal amphipathic domain. Alpha-Synuclein is a 14 kD (140 amino acids) acidic presynaptic protein. It is a major component of Parkinson’s disease aggregates and is implicated in the pathogenesis of Parkinson’s Disease and related neurodegenerative disorders. Alpha-Synuclein accumulates in the brains of sporadic Parkinson’s disease patients as a major component of Lewy bodies, which are intraneuronal cytoplasmic inclusions characteristic of Parkinson’s disease. Alpha-Synuclein appears to associate with other proteins that aggregate and is found in amyloid plaques and neuritic tangles in Alzheimer’s disease.
References:
Conway, K.A. et. al., (2000) Biochemistry, 39: 2552
Jakes, R. et al. 1994, FEBS Letters, 345, 27
Masliah, E. et. al., 2001. Proc. Natl. Acad. Sci., USA, 98, 12245
Ueda, K., et. al. 1993. Proc. Natl. Acad. Sci., USA, 90, 11282
Alpha Synuclein, 1-95
MW: 9,391 Da
Description: Lyophilized powder. Purity > 95% by SDS-PAGE; A deletion mutant of Alpha-Synuclein (amino acids 1-95), which contains the N-terminal amphipathic domain and the NAC region. Alpha-Synuclein is a 14 kD (140 amino acids) acidic presynaptic protein. It is a major component of Parkinson’s disease aggregates and is implicated in the pathogenesis of Parkinson’s Disease and related neurodegenerative disorders. Alpha-Synuclein accumulates in the brains of sporadic Parkinson’s disease patients as a major component of Lewy bodies, which are intraneuronal cytoplasmic inclusions characteristic of Parkinson’s disease. Alpha-Synuclein appears to associate with other proteins that aggregate and is found in amyloid plaques and neuritic tangles in Alzheimer’s disease.
References:
Conway, K.A. et. al., (2000) Biochemistry, 39: 2552
Jakes, R. et al. 1994, FEBS Letters, 345, 27
Masliah, E. et. al., 2001. Proc. Natl. Acad. Sci., USA, 98, 12245
Ueda, K., et. al. 1993. Proc. Natl. Acad. Sci., USA, 90, 11282
Alpha-Synuclein, 61-140
MW: 8,460 Da
Description: Lyophilized powder. Purity > 95% by SDS-PAGE; A deletion mutant of Alpha-synuclein (amino acids 61-140). Additional amino acid (Met) is attached at the N-terminus. Alpha-Synuclein is a 14 kD (140 amino acids) acidic presynaptic protein. It is a major component of Parkinson’s disease aggregates and is implicated in the pathogenesis of Parkinson’s Disease and related neurodegenerative disorders. Alpha-Synuclein accumulates in the brains of sporadic Parkinson’s disease patients as a major component of Lewy bodies, which are intraneuronal cytoplasmic inclusions characteristic of Parkinson’s disease. Alpha-Synuclein appears to associate with other proteins that aggregate and is found in amyloid plaques and neuritic tangles in Alzheimer’s disease.
References:
Park, S. M. et al. (2002) Blood, 100(7) 2506
Park, S. M. et al. (2002) Biochemisty. 41, 4137
Conway, K.A. et. al., (2000) Biochemistry, 39: 2552
Jakes, R. et al. 1994, FEBS Letters, 345, 27
Masliah, E. et. al., 2001. Proc. Natl. Acad. Sci., USA, 98, 12245
Ueda, K., et. al. 1993. Proc. Natl. Acad. Sci., USA, 90, 11282
Alpha-Synuclein, 96-140
MW: 5,217 Da
Description: Lyophilized powder. Purity > 95% by SDS-PAGE; A deletion mutant of Alpha-Synuclein (amino acids 96-140). Additional amino acid (Met) is attached at the N-terminus. Alpha-Synuclein is a 14 kD (140 amino acids) acidic presynaptic protein. It is a major component of Parkinson’s disease aggregates and is implicated in the pathogenesis of Parkinson’s Disease and related neurodegenerative disorders. Alpha-Synuclein accumulates in the brains of sporadic Parkinson’s disease patients as a major component of Lewy bodies, which are intraneuronal cytoplasmic inclusions characteristic of Parkinson’s disease. Alpha-Synuclein appears to associate with other proteins that aggregate and is found in amyloid plaques and neuritic tangles in Alzheimer’s disease.
References:
Park, S. M. et al. (2002) Blood, 100(7) 2506
Park, S. M. et al. (2002) Biochemisty. 41, 4137
Conway, K.A. et. al., (2000) Biochemistry, 39: 2552
Jakes, R. et al. 1994, FEBS Letters, 345, 27
Masliah, E. et. al., 2001. Proc. Natl. Acad. Sci., USA, 98, 12245
Ueda, K., et. al. 1993. Proc. Natl. Acad. Sci., USA, 90, 11282
Lock ALL Articles within the Industry of Your Choice! And CATCH Visitors via Your Competitors'
Pharma/BioTech/Nutrition Announcements
Health Article Comments
- Health boards looking to increase transparency »»»
- Napp Pharmaceuticals found to breach MHRA advertising guidelines »»»
- Pharmacy care program helps elderly take their medications »»»
- Minds may need changing »»»
- The harmful pressure of market forces »»»
- Prescription for closing community pharmacies? »»»
- Health research serves profit rather than the public »»»
- Whose DNA is it anyway? »»»
- Need not greed »»»
- Drugs dominate response to mental health problems »»»
- Online Pharmacy Links
- Health News and Articles
- At right angles to Health
- Walker Online Pharmacy
- Weight Loss Online Books
- Pharmacy Drugs-Zone
- Medical Search Engine
- Online Broker for Pharmacies
- Medicalmanagement.Ag
- Pharmamedics Drugs Broker
- Health News 247
- The Xanax
- Beauty news
- Beauty Weblog
- Weight Loss Weblog
- All About Beauty
- Pharmasellers.com
- Drugshop247.com Online Pharmacy
- Pharmacy2u
- PharmacyInfo
- Online Pharmacy FDA
- AnxietyOnlinePharmacy
- 1stCanadaMeds
- BuyCanadianPharmacy
- OrderCheapDrugs
- OnlinePharmacyChoice
- OnlinePharmacyChecker
- PharmaInspector.com
- EDPharmacyDrugs.com
- anxietypharmacy.blogspot.com
- mentaldisordersinfo.blogspot.com
- anxietydepressiontips.blogspot.com
- mentalhealthdisorders.blogspot.com
- mentalguide.livejournal.com
- edpharmacy.wordpress.com
- menshealthzone.wordpress.com
- edmenshealth.wordpress.com
- menshealthtips.livejournal.com
- mentalguide.livejournal.com
- healthpharmacydrugs.blogspot.com
- healthpharmacy.wordpress.com
- piart.com.ua
